{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-050397","form_type":"8-K/A","ticker":null,"cik":"0001839998","company_name":"American Oncology Network, Inc.","filed_at":"2024-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.963869+00:00","generated_at":"2026-05-28T23:22:31.944189+00:00","sec_items":["2.01","2.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"American Oncology Network completes acquisition of Central Georgia Cancer Care for ~$13.3M","bullets":["Acquisition of CGCC assets for $4.6M cash, $6.4M promissory note (60-month term), and ~$2.3M for inventories.","CGCC had $102.7M patient revenue in 2023, net loss of $1.03M, and total assets of $18.6M.","$6.4M note requires monthly payments of $106,667 plus interest at AON's variable borrowing cost.","CGCC operates two oncology practice locations in Macon and Warner Robins, Georgia.","Amendment corrects omitted date in audit report; no change to prior disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-050397","json":"https://secwatch.observer/filing/0001140361-24-050397.json","markdown":"https://secwatch.observer/filing/0001140361-24-050397.md","text":"https://secwatch.observer/filing/0001140361-24-050397.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839998/000114036124050397/0001140361-24-050397-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839998/000114036124050397/ef20040705_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:22:31.944189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c477be19c6f0a1182b2ffbb511f108857b205215","claim":"American Oncology Network, Inc. completed an acquisition involving Central Georgia Cancer Care, P.C. shareholders for $4.6 million cash, $6.4 million promissory note, and approximately $2.3 million cash for inventories (closed 2024-04-01).","evidence_excerpt":"On April 1, 2024, consolidated subsidiaries of American Oncology Network, Inc. (“AON” or the “Company”) acquired certain clinical and non-clinical assets of Central Georgia Cancer Care, P.C., (“CGCC”) from the CGCC shareholders for consideration consisting of (i) a cash payment in the amount of $4.6 million, (ii) a promissory note in the amount of $6.4 million under which the terms require principal and interest payments in monthly installments over 60 months commencing May 1, 2024, and (iii) a cash payment of approximately $2.3 million for acquired inventories, (the “CGCC Acquisition”).","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1839998/000114036124050397/0001140361-24-050397-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Central Georgia Cancer Care, P.C. shareholders"},{"label":"Consideration","value":"$4.6 million cash, $6.4 million promissory note, and approximately $2.3 million cash for inventories"},{"label":"Closing","value":"2024-04-01"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}